Absci (ABSI) EBITDA Margin (2020 - 2026)
Absci's EBITDA Margin was -9893.71% in Q2 2026, down 5105.68 percentage points from -4788.03% a year earlier but up 3184.43 percentage points from the prior quarter.
Powered by 
Analysis
Absci (ABSI) EBITDA Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Absci's EBITDA Margin was -7373.80% through Jun 30, 2026, down 4833.20 percentage points year-over-year; for FY2025, it was -3877.68%, down 1771.39 percentage points from FY2024.
- EBITDA Margin has now declined for five consecutive years, with a five-year change of -3623.08 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was -2106.29% in FY2024 (-330.91 pp), -1775.38% in FY2023 (-144.73 pp), -1630.64% in FY2022 (-196.43 pp) and -1434.21% in FY2021 (-1179.61 pp).
- Quarterly EBITDA Margin has moved between -13078.14% (Q1 2026) and -1036.85% (Q3 2022) over five years.
- Compared with a year earlier, EBITDA Margin has declined for five straight quarters, with an average year-over-year change of -2689.43 percentage points over the last eight quarters.
- The best year-over-year quarter for EBITDA Margin over five years was Q4 2024 (a gain of 2297.48 percentage points); the worst was Q1 2026 (a drop of 10986.79 percentage points).
- Per Business Quant data, ABSI's EBITDA Margin in the three quarters before Q2 2026 was -13078.14% (Q1 2026), -4340.46% (Q4 2025) and -7225.40% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Absci | 1.63 Bn | 1.01 Bn | - | -9,893.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9,893.71% |
| Mar 31, 2026 | -13,078.14% |
| Dec 31, 2025 | -4,340.46% |
| Sep 30, 2025 | -7,225.40% |
| Jun 30, 2025 | -4,788.03% |
| Mar 31, 2025 | -2,091.35% |
| Dec 31, 2024 | -3,990.98% |
| Sep 30, 2024 | -1,501.47% |
| Jun 30, 2024 | -1,837.56% |
| Mar 31, 2024 | -2,236.30% |
| Dec 31, 2023 | -6,288.46% |
| Sep 30, 2023 | -2,659.95% |
| Jun 30, 2023 | -1,172.85% |
| Mar 31, 2023 | -1,653.35% |
| Dec 31, 2022 | -1,124.41% |
| Sep 30, 2022 | -1,036.85% |
| Jun 30, 2022 | -2,569.46% |
| Mar 31, 2022 | -3,162.03% |
| Dec 31, 2021 | -1,618.25% |
| Sep 30, 2021 | -1,229.63% |
API Access
Absci EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ABSI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ABSI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ABSI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();